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Reimbursement schemes in intensive care are more complex than in other areas of healthcare, due to special
procedures and high care needs. Knowledge regarding the principles of functioning in other countries can lead
to increased understanding and awareness of potential for improvement. This can be achieved through mutual
exchange of solutions found in other countries. In this review, experts from eight European countries explain
their respective intensive care unit reimbursement schemes. Important conclusions include the apparent
differences in the countries’ reimbursement schemes-despite all of them originating from a DRG system-, the
high degree of complexity found, and the difficulties faced in several countries when collecting the data for
this collaborative work. This review has been designed to assist the intensivist clinician and researcher in
understanding neighbouring countries’ approaches and in putting research into the context of a European
perspective. In addition, steering committees and decision makers might find this a valuable source to compare
different reimbursement schemes.
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Over the recent years, research regarding costing and
reimbursement have gained growing appreciation within
the field of intensive care. One reason may be that intensive
care units (ICUs) are considered to be the most expensive
departmental structures in hospitals [1]. High costs of
personnel, complex procedures and expensive medical
devices, equipment, and infrastructure contribute to this
fact [2-4]. Intensive care costs play an important role in
hospital economics—both for the respective intensive care
unit, the hospital it belongs to, and the healthcare system
eventually reimbursing the costs.
Several studies have analysed the generation of costs in
ICUs, partly also comparing procedures in different coun-
tries [5,6]. However, to date there is no widely accessible
information in a scientific setting about how costs are
reimbursed in the ICU setting in different countries.* Correspondence: martin.bittner@neptun.uni-freiburg.de
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in any medium, provided the original work is pHowever, the adequate reimbursement of costs is of para-
mount importance for ICUs.
Therefore, national experts for ICU reimbursement and
costing issues were contacted and asked for collaboration
(see Table 1 for the original questionnaire). The primary
goal of this collaborative effort was to give a comprehensive
overview about how reimbursement works in a selection of
European countries. A diversified convenience sample of
eight European countries has been chosen to represent the
differences in the European ICU setting. The inclusion of
national experts was the key to be able to identify and
explain the national systems, in many cases only rendered
possible through their personal experience in the respective
country’s system (thereby not even taking into account
language barriers). The information generated by this
amalgamation of different countries’ perspectives can be
used to enhance mutual knowledge about problems faced
and approaches found elsewhere (see Table 2 for a general
overview on the countries’ healthcare systems).
This also can be valuable for informing policymakers,
directly influencing amendments and corrections to the
systems currently used. It has to be highlighted that then open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Original questionnaire used to inform all authors about uniform requirements
Health system – key facts - Principal mode of financing (e.g., tax-based, insurance-based)
- Number of patients admitted to hospitals per year (country-wide)
ICUs – key facts - Number of patients admitted to ICUs per year (country-wide)
- Number of ICUs (country-wide)
Reimbursement scheme Please describe in detail, how ICU costs are being measured and how the reimbursement is being
calculated; please refer to the clinical routine, as used in daily work:
- Necessary documentation (is there extra documentation for budgeting purposes, or is the standard
clinical documentation used?)
- Coding (e.g., in a DRG-based system, where reimbursement is linked to diagnosis)
- Are there differences concerning reimbursement of surgical vs. medical intensive care unit patients
- Are there differences concerning reimbursement schemes for teaching hospitals and non-teaching
hospitals (teaching refers to the education of physicians)
- Possible modifiers (e.g., when a patient has to receive expensive medication, develops complications etc.)
- What are, in your opinion, the most important advantages and disadvantages of your reimbursement
scheme
- Personal opinion: please explain, if you perceive a major imbalance between costs and reimbursement,
i.e., if the reimbursement scheme does not adequately reflect the necessary clinical care
References Please give references for the statements made; please feel free to include additional study results into
the personal opinion part (e.g., a study conducted in your country validating your opinion or adding a
crucial point)
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ICUs also directly affect healthcare costs. We hope that
this overview is to be seen as a valuable tool for other
researchers working in the field of ICU cost-reporting
and cost-generation, who might find it useful to place
their findings into a European context. In the following




The German reimbursement scheme is in general based
on a DRG system (diagnosis-related groups). The basic
concept is the combination of a main diagnosis derived
from the ICD-10 (International Statistical Classification
of Diseases and Related Health Problems 10th Revision)
catalogue and secondary diagnoses as well as procedures
listed in the OPS-301 (Operationen- und Prozedurens-
chluessel = operations and procedures classification) cata-
logue to form a basic DRG code. This basic DRG code can
be modified according to the Patient Clinical Complexity
Level, yielding the final DRG code which is reimbursed
[18]. Compared with the original version, the System Ver-
sion 2010 included many new features dealing with the
special needs of ICUs. The 2010 system was made substan-
tially more complex with the aim of improving the correl-
ation between costs and reimbursements in the intensive
care setting [19]. Key components of the German reim-
bursement scheme in the ICU setting include the possi-
bility of varying existing diagnoses by makingamendments which specify the individual patient’s health
status.
The first specification is the length of mechanical ventila-
tion. It can be coded in intervals starting with a minimum
length of 96 h.
The second is the so-called intensive care complex
treatment. This is an additional feature which is bound to
prerequisites, such as continuous physician’s attendance
and a patient’s minimum stay on the ICU of 24 h, and is
formed by adding point values for special efforts in care.
These point values are a combination of a daily assessment
incorporating the New Simplified Acute Physiology Score
(equal to SAPS II without Glasgow Coma Scale) and an
assessment of ten daily activities from the TISS-28 (Thera-
peutic Intervention Scoring System) catalogue.
The third specification involves complicating procedures.
These may include blood products, chemotherapy, central
venous catheters, or pacemakers and also additional diag-
noses, such as severe inflammatory response syndrome,
which are combined in a multifactor-approach.
Together, these three specifications allow for a much
greater variability of ICU cost reimbursement. There-
fore, high standards of documentation have to be main-
tained. In addition to the standard documentation of
clinical parameters and procedures, it also is necessary
to address the features introduced above. This means,
the relevant scores have to be administered and the ful-
filment of other prerequisites has to be controlled. There
is no difference concerning reimbursement of surgical
versus medical intensive care unit patients. There also
Table 2 Overview: key data regarding the healthcare system and intensive care units in the countries covered in this review



















Germany [7] 82 Mio Insurance-based (statutory health
insurance 90%, private medical
insurance 10%)
1260 31.8 25,500 17 Mio 2 Mio. 12% 1092 Yes
Ireland [8] 4.6 Mio Tax-based 28 5,4 250 580,000 30,000 5% 2205b Yes
UK [9] 62 Mio Tax-based 290a 7.5 4,700 17 Mio 200,000 1% 1500 No
Netherlands [10,11] 16.7 Mio Insurance-based 94 9.3 1,600 1.9 Mio 70,000 4% 1290 Yes
Austria [12] 8.4 Mio Insurance-based 132 27 2,300 2.8 Mio - - 2000c No
Denmark [13,14] 5.4 Mio Tax-based 49a 7.5 400 1.1 Mio 33,000 3% 3302c No
France [15] 65 Mio Insurance-based
(statutory health insurance)
238 11.2 7,300 17 Mio 200,000 1% - Yes
Spain [16,17] 47 Mio Tax-based 300a 7.4 3,500 5.3 Mio 240,000 5% 900 to 2500 Yes
aTotal number of ICUs.
bOnly known for 1 hospital, AMNCH Tallaght.
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for teaching hospitals versus nonteaching hospitals.
However, the costs of ICUs in bigger hospitals appear to
be higher than in smaller hospitals, which is probably
due to a higher proportion of more cost-intensive surgi-
cal patients [20].
The increasing complexity of the German ICU reim-
bursement scheme requires a demanding amount of docu-
mentation and coding. This may be seen as a trade-off for
a potentially higher accuracy of cost portrayal.
The system is subject to regular updates: Each year, an
updated catalogue of billable DRGs is prepared, based on
performance and cost data from voluntarily participating
so-called “calculation hospitals”.
Ireland
Public hospitals are funded using block grant historical
budgets, i.e., the previous year’s baseline allocation is
generally rolled forward into the following year and then
adjusted for in year national economic factors. Inherent
in the funding model is the assumption that hospitals
will generate a level of private health insurance income
that will reduce the absolute funding amount required
from the Health Service Executive to deliver services.
Modifications to historical budgets generally include any
nationally agreed changes to Department of Health pay
scales, inflation, changes in taxes, and top slicing efficiency/
“value for money” targets.
Each department in a hospital functions as a costing
centre. It has fixed costs, such as amenities and staff
wages, etc., and variable costs, such as medications and
equipment. The fully absorbed overall costs are averaged
to patient bed days, and thus a cost is assigned to a
patient.
The cost-effectiveness is based on a DRG system, which
derives diagnosis from the ICD-10 catalogue. All patients
are coded by trained clinical coders using a chart review.
Standard clinical documentation is largely used for coding
purposes, although local arrangements may exist in some
hospitals to enhance accuracy of coding (e.g., a special
discharge summary may be completed by the ICU and
or admitting teams to facilitate coding by coders). It is
notable that coding, and hence costing, is currently done
retrospectively, i.e., following discharge of the patient.
The coding will then generate a DRG that is assigned a
relative value, which will then provide a cost, the average
cost of a patient with that diagnosis. This is compared to
the actual cost of a patient and a casemix adjustment is
derived. Hospitals are compared to each other nationally,
but they are divided into groups with large teaching hospi-
tals in group 1, smaller hospitals in group 2, and stand-
alone paediatric hospitals in group 3. Based on the casemix
adjustment per hospital per group, the fixed budget can
then be rewarded or penalised depending on performance.Therefore, the DRG coding is used as a performance indi-
cator and not directly for reimbursement. There are no
specific DRG codes for common ICU diagnoses, such
as acute respiratory distress syndrome, multiple organ
failure, or severe sepsis, which are primarily physiological
diagnoses. Costly ICU treatments are primarily directed at
correcting acute physiological abnormalities.
The actual reimbursement of ICU is not direct, because
the ICU also functions as a costing centre. The patient
bed days are divided up amongst the varying specialities
with patients in the ICU. The percentage of bed days is
then worked out per speciality and thus the speciality
accrues that percentage of the total cost of ICU, which
then comes out of the budget of that speciality.
There is no difference between medical and surgical
patients as regards to reimbursement nor are there differ-
ences in reimbursement schemes for teaching hospitals
versus nonteaching hospitals (except for the groups named
above). Comparing ICUs from the different types of cen-
tres is difficult as more complex patients are generally
cared for in the larger hospitals.
Possible modifiers for more expensive treatments (a
“special costing submission”) can be submitted to the
Health Service Executive. This is assessed by the Health
Service Executive and considered for inclusion in the
following year’s budget. National specialty considerations
also can be applied for if appropriate. Both the shape and
structure of critical care delivery as well as the mechanism
of funding of hospitals is under review with aims for
profound changes (moving to a more patient-level costing
system, more accurately reflecting the cost of a patient’s
intensive care and hospital stay).
United Kingdom
General funding revolves around a system of activity
based funding known as Payment by Results [21]. Funding
is calculated separately from the admission diagnosis
funding, which is based on organ support derived health-
care resource groups (HRG). Each patient will have an ad-
mission HRG and then a separately derived critical care
HRG also applies. Each critical care admission episode
(spell) has a critical care minimum data set HRG calcu-
lated on the basis of the total number of organs supported
during the patients stay [22]. This then provides a day
rate, which is multiplied by the duration of the spell to cal-
culate a total cost/reimbursement for the episode.
The critical care minimum data set is part of the hos-
pital episode statistics dataset, which is held by the Na-
tional Health Service information authority. This data is
then returned to the hospitals via the secondary user
service for sense checking. A grouper software is used to
derive the HRG from the organ support data supplied.
Since 2011, the currency (i.e., the HRG) has been na-
tionally mandated; however, the tariff (payment) has been
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from hospitals using annually updated guidance, thereby
acting as a benchmark [23,24].
There is no difference in the reimbursement between
larger and smaller units, medical versus surgical units, or
teaching versus nonteaching hospitals. Some treatments,
such as haematological drugs, are excluded from the
payment by results system and reimbursed separately. At
the moment, there is no information accessible regarding
changes in the system currently in use.
Netherlands
The reimbursement scheme is based on a DRG system,
which has been introduced in 2005 and since then is being
revised regularly. The number of DRGs has been reduced
from 30,000 to 4,400 grouped DRGs in 2012 and the
system is based on ICD-10 diagnoses [25].
Activity-based costing studies in ICUs demonstrated
that time for patient care and costs were poorly associated
with diagnosis but better reflected by staffing patterns,
ICU levels, and a number of cost drivers, such as admis-
sion process, ICU length of stay, (non)invasive mechanical
ventilation, haemodiafiltration, hospital consultation, and
transportation (mobile intensive care) [26,27]. Intensive
care costs add up to admission DRGs with special financial
products for reimbursement (ICU add-ons). During ICU
admission, all costs incurred (staffing, equipment, medi-
cations, disposables, laboratory testing, diagnostic proce-
dures, and medical consultations) are components of the
ICU budget and not part of the DRGs. The ICU incomes
are based on add-on products and based on three ICU
costing groups reflecting ICU complexity levels, arbitrarily
divided into less than 1,000, 1,000 to 1999, and more than
2,000 days of mechanical ventilation per year.
Costs are reimbursed for fixed prices per treatment
day (a), additional admission charge (b), (only first day),
(non)invasive ventilation (c), and haemodiafiltration (d)
surcharge fees and based on a normative ratio 20(a): 5(b):
4(c): 3(d) from the activity-based costing study [28,29].
Parallel to honorarium for intensivists the hospital costs
are reimbursed using the same add-ons based on the
three costing groups based on average hospital costs for
ICU in 24 hospitals in 2006. Since then, prices have been
indexed [30].
Due to the simplicity of the system, insurance companies
can easily sample data from medical records to validate
hospital claims for reimbursement. Analysis of combina-
tions of DRGs and ICU add-ons may be of additional value.
There are no differences concerning reimbursement of
surgical versus medical intensive care unit patients. Fur-
thermore, there are no differences concerning reimburse-
ment schemes for teaching hospitals and nonteaching
hospitals. The cost groups with higher volume of ventilated
patients circumvent this aspect. Because all costs are in theICU day price, normally no additional fees for procedures
of medications are available. However, a few expensive
medications, such echinocandins, can be additionally
reimbursed [31]. In case of complications and prolonged
length of stay, all ICU costs will be reimbursed.
In the future, intravenous cooling devices will be reflected
by an additional fee. Due to trends of concentration in
intensive care medicine, the system has to be updated to
financially facilitate regional ICU systems in the interest
of better regional ICU care.
Austria
The Austrian health care plan distinguishes between inter-
mediate or coronary care units and intensive care units.
Intensive care units are separated into three categories
ranging from category 1 to 3, with category 3 ICUs con-
sidered to provide care for the most severely ill patients.
Classification into the three categories is based on average
TISS-28 score generated over a year by each unit, with only
TISS-28 scores higher than 16 being accounted (category 1:
TISS-28 > 22; category 2: TISS-28 > 27; category 3: TISS-
28 > 32). Every ICU category also is defined by several
quality criteria that have to be fulfilled, such as minimal
number of beds (i.e., six), nurse to patient ratio, level of
specialisation required for physicians in charge of the unit,
as well as for coverage during on-call hours.
ICU costs are measured as the sum of personnel costs
and costs arising from consumables as well as from acqui-
sition of new devices. Income results from reimbursement
paid by the provincial hospital financing funds on basis of
the LKF system (Leistungsorientierte Krankenhausfinanzier-
ung = performance-based hospital reimbursement), which
is an Austrian performance-related hospital financing
system [32]. The LKF system is basically a modified DRG
system, which has been introduced in 1997 and revised
on an annular basis since then. The basic concept is the
combination of main diagnoses derived from the ICD-10
catalogue and individual medical procedures (e.g., surgery,
dialysis), which combine to an overall of 982 case groups.
Each of these case groups is reimbursed by a certain num-
ber of LKF points. For ICU patients, extra reimbursement
is calculated per ICU day, which is increasing from cat-
egory 1 to category 3 units by a factor of roughly times 1.5.
Additional reimbursement is generated for each defined
medical procedure (e.g., bronchoscopy, ultrasound, specific
antibody treatment) provided for the patients.
Documentation officially required by the ministry of
health and the hospital administration are ICD-10 diagno-
ses and daily TISS-28 scoring, which determines ICU cat-
egorisation. Furthermore, SAPS II scoring on admission is
compulsory. SAPS II scoring is used by the authorities for
plausibility checks of the TISS-28 scores generated by each
unit. Obviously, all medical procedures provided have to be
documented. The TISS-28 scoring system favours surgical
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resulting in surgical units reaching higher categories as well
as reimbursements [33].
Generally speaking, there are no differences in the re-
imbursement scheme between different types of hospital,
i.e., teaching versus nonteaching hospitals. However, the
final conversion for generated LKF points into Euros
varies between the nine provinces of Austria and is mainly
(politically) determined by provincial governments.
Also, the same reimbursement system applies to surgical,
medical, neurological, or mixed intensive care units.
However, reimbursement in surgical ICUs tends to be
higher due to more frequent medical procedures provided
to surgical patients.
A change in reimbursement as well as categorisation
of ICUs will take place in 2014. The new system will be
based on TISS-A and SAPS 3 [34] scoring. Additional
compulsory documentation of these new scores has
started in 2012 and their results will be used for definition
of the new system (TISS-A score is a modified TISS-28
score with additional emphasis on mode of ventilation,
(noninvasive) haemodynamic monitoring, agitation and
delirium, assist devices (cardiac, pulmonary, liver), and
therapeutic hypothermia [35]).
Denmark
Developed and initiated by the Danish National Board of
Health and the Danish Society of Anaesthesiology and
Intensive Care, a new model for improvement of DRG
registrations in the ICUs was implemented in 2004. The
Danish ICU-DRG system consists of four groups reflect-
ing progressive deterioration in organ failure [36]. A set
amount is assigned to each of these groups. The rules
for allocation to one of the four ICU-DRG groups are
based on a combination of 42 intensive procedure-
related codes restricted with specific demands for the time
interval of ICU length of stay and length of mechanical
ventilation [37].
A prerequisite for allocation to one of the four in-
tensive groups is the provision of an intensive-related
procedure code and admission to an intensive care
unit for more than 72 hours. The purpose of the 72-
hour limit is to weed out the less resource-demanding
acute patients and the elective surgical intensive recov-
ery process, as it was the Danish National Board of
Health’s belief that the main hospitalization costs for
these patient groups were outside the intensive care
area.
The four ICU-DRG groups are:
ICU-DRG group I: Simple organ failure in one or two
organs – Hospital length of stay 10 days (mean)
ICU-DRG group II: Progressive severe organ failure in
one organ – Hospital length of stay 12 days (mean)ICU-DRG group III: Progressive severe organ failure in
two organs or more – Hospital length of stay
14 days (mean)
ICU-DRG group IV: Severe multi organ failure – Hospital
length of stay 17 days (mean)
These four ICU-DRG groups are independent of the
ICU level or category, ranging from one to three. Pa-
tients admitted to the ICU with an ICU length of stay
less than 72 hours are reimbursed on the concept of a
combination of a main diagnosis derived from the ICD-
10 catalogue, secondary diagnoses, and procedure-
related codes.
There is no difference concerning reimbursement of
surgical versus medical ICU patients and no differences
concerning reimbursement schemes for teaching versus
nonteaching hospitals.
The ICU-DRG grading system does not contain reim-
bursement for patients receiving very expensive medication
or for patients developing severe complications except for
those expressed in one of the 42 intensive procedure-
related codes. The ICU-DRG accounting system is eval-
uated by the Danish Ministry of Health with annual adap-
tion of the DRG pricing by the use of national databases
and cost registers.France
In 2002, a definition of ICU was issued by the French
authorities with further details published in 2003. There
was a strong recommendation for having an intermediate
care unit along with the ICU.
The hospital funding through the DRGs was progres-
sively introduced since 2004 and fully applied in 2008. The
DRGs were refined in 2010 with four levels of severity
mainly relying on comorbidities. The rules are revised every
year (classification algorithm and tariffs) [38].
On top of DRG, French ICUs benefit from a comple-
mentary funding if the following three criteria are verified:
patients treated in an official ICU fulfilling the nationwide
criteria (board certified ICU physician, 24-h coverage by
an ICU physician dedicated to the ICU, at least 1 nurse
for 2.5 patients and 1 nurse’s help for 4 patients [39]),
SAPS II > 15 and at least one specific ICU procedure
performed during the ICU stay, such as mechanical venti-
lation, renal replacement therapy, or vasoactive drugs [38].
This extra funding accounts for 60% of the total payment
of ICUs.
Some expensive drugs, such as modern antifungal treat-
ment, immunoglobulin, and modern chemotherapy, are
paid independently from DRG if several criteria are fulfilled:
drug belonging to a restricted list (<100, updated every
year), formal indication approval by health authority,
individual prescription, and central preparation by
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for the students, the innovation and research assessed
through the number and quality of publications and num-
ber of ongoing trials. In addition, there are efforts to obtain
extra funding from the ministry of health by scientific
societies and hospital federations gathering all hospital
across France to help meet the financial needs of ICUs.
Spain
The system is characterized by its decentralized conception,
i.e., the autonomous regions of the country (17 plus 2
autonomous cities) have the authority on medical issues,
although the coordination between territories is ensured.
In a universal health care system financed by taxes, the
reimbursement is not the main objective in the costs
allocation process. The calculation of the costs is used as a
tool for comparison between centres and regions and as a
quality control indicator of the medical care. However,
it also is necessary for making the insurance dependent
payments (traffic and labour accidents) and of services
offered by private hospitals.
The decentralization of the health system has led to
differences in the development and implementation of
cost-accounting models developed by the different autono-
mous regions. In general, the basic model requires that all
hospitals use the Minimum Basic Data Set which includes
patient variables, episode, diagnosis (ICD-9), and codified
procedures. This dataset is obtained from standard clinical
documentation. The information is channelled through the
autonomous regions and reaches the Ministry of Health,
which calculates the reference weights of the DRGs. For a
particular DRG, a comparison between the reference
and calculated weights at each hospital can be established.Table 3 Basic mode of functioning of the respective national
Basic modes of functioning ( “++” strongly agree, “+” agree, “0” indiffe
Item
The reimbursement works per case (e.g., DRG-based).
The reimbursement works per ICU/hospital (e.g., share of reimbursement
goes to all units involved).
There is separate reimbursement for hotel costs.
The following factors are taken into account for coding/reimbursement:
1. Previous year’s ICU expenditure
2. Number of patients
3. Diagnosis (DRG)
4. Nursing workload scores (e.g., TISS-28, NEMS)
5. Severity of illness scores (e.g., SAPS, APACHE)
6. Length of stay
7. Level of organ support
Are there any plans for changes of the system in the near future?The value of the weight integrates the information of the
Minimum Basic Data Set with the hospital costs. Some re-
gions use more advanced models, such as the International
Refined DRG. Other regions also have implemented
improvement and audit procedures of diagnostic coding,
seeking to establish a common price by DRG, and use the
model based on DRGs for the payment of the services
offered by private hospitals [40].
In Spain, there are no differences concerning reimburse-
ment schemes for teaching hospitals and nonteaching hos-
pitals. There are no changes concerning the reimbursement
of medical versus surgical intensive care unit patients or
by the use of very expensive treatments or procedures.
However, the system penalizes patients who undergo
surgical procedures, assigning weights in a disproportionate
way [41].
These problems have led to the search for improvement
measures based on nationwide initiatives and opinions
from scientific societies and private companies [42]. These
measures should achieve the goal of a single reimburse-
ment system that takes into account the diagnosis (using
a proper ICU coding), patient severity (using severity scales
and patient classification categories), specific ICU pro-
cedures (using scales of therapeutic interventions), and
complications during hospital evolution [43].
Conclusions
Our study presents how intensive care reimbursement
works in eight European countries. The national experts’
contributions allow for clinicians to understand the mode
of functioning in neighbouring countries. At the same time,
researchers in the field of health care services can draw on
this resource when putting their or others’ research into anICU reimbursement schemes, based on experts’ responses
rent or unknown, “-“ do not agree, “–“do not agree at all)
Grading
GER IRL UK NETH AUS DEN FRA SPA
++ - + ++ ++ ++ + +
– + - + + - 0 0
– - + – - – – 0
– - - – - + – +
– - + + + 0 + +
++ + + + + + + +
+ – + - ++ - – 0
++ – - - – - + 0
+ + + ++ + ++ ++ ++
+ – ++ ++ + ++ ++ +
+ + 0 + + – 0 0
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may be for those interacting with policymakers, thereby
using this review as a source of information to present
other countries’ systems. However, given the data pre-
sented in this work, we do not feel confident to make
recommendations about the appropriateness and usefulness
of certain systems. This would require a different method-
ology, ideally employing direct comparisons of standardized
sample cases within certain countries, addressing both
cost calculation and reimbursement. So far, these data do
not exist for the ICU setting.
We present a sample of eight European countries,
which was the result of a collaborative effort to include a
variety of countries, thereby at no time making a claim
to be exhaustive. In contrast, the sample was restricted
by the identification of national experts, their willingness
to contribute to this project and the timely realisation of
the exchange between the experts (set to be 6-9
months). It has to be pointed out that the comparisons
between countries within the setting of this collaborative
project also face limitations. One important aspect is the
underlying definition of intensive care units and inten-
sive care patients, especially when differentiating high-
dependency units, intermediate care units, or critical
care units, as well as paediatric intensive care units or
even contrasting medical or surgical ICUs. We cannot
account for this variety of terms and definitions, which
can be further complicated by different expressions in
the various languages. Therefore, this work concentrated
on intensive care units in the respective national defin-
ition, thereby excluding the other types of units, as
much as possible. Still, considerable differences in the
average ICU patient spectrum cannot be ruled out. This
also may at least partly explain differences seen in the
relative number of ICU beds and patients per country.
Finally, we would like to point out some key points
regarding the data presented in this review. First, the
variety in approaches used within the selection of
eight European countries has to be highlighted. The
ICU reimbursement schemes differ greatly, despite
usually being based on DRG models. This also under-
lines the importance of the alterations made in the
specific systems, which also may make it possible in
the future to adapt the systems to lessons learnt in
other countries. To make both similarities and differ-
ences more transparent, Table 3 summarizes the ex-
perts’ degree of agreement to statements regarding
the inclusion of certain factors into the respective re-
imbursement schemes. This may be used for stan-
dardized comparisons.
Second, reimbursement in the intensive care setting
often is highly complex. Therefore, it requires skilled
personnel to work in this area. This also is an opportun-
ity for both intensive care and public health research,especially in the educational setting, striving for greater
transparency and understanding.
Another interesting finding from our study is the great
variety in access to information regarding national reim-
bursement schemes. Whereas some experts were able to
build upon national guidelines or published reports, others
reported that finding out about the systems in use and their
respective mechanisms was a difficult and time-consuming
process. Data collection was within the individual national
expert’s competence, thereby taking advantage of experi-
ence in the matter as well as language competence. In the
end, authors from five countries reported difficulties in
finding the requested information, whereas in three coun-
tries information retrieval has been reported to be relatively
easy. The data sources mostly used were national statistical
data, original literature, and national healthcare reports.
This is certainly an important finding, highlighting the im-
portance of accessible information about reimbursement
schemes as given through this review.
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